Introduction {#s0005}
============

Many intracellular reduction--oxidation (redox) processes are directly or indirectly linked to the redox-active, tripeptide-like compound glutathione [@bib1]. Glutathione is composed of the three amino acids glutamate, cysteine, and glycine and exists as a mixture of its reduced form, GSH, and its disulfide-linked dimeric form, GSSG. The biosynthesis of glutathione takes place in the cytosol, from where it is transported to other cellular compartments [@bib2]. As intracellular glutathione concentrations are in the millimolar range, its compartment-specific status is considered a major determinant of intracellular redox environments [@bib3]. The reductive (or oxidative) power of glutathione is defined by its electrochemical half cell reduction potential (*E*~GSH~), calculated from its standard reduction potential (*E*°\'=−240 mV) and the concentrations of GSH and GSSG using the Nernst equation (Eq. [(1)](#eq0005){ref-type="disp-formula"}) where *R*=8.315 J K^−1^ mol^−1^ is the gas constant, *T*=298 K the temperature, and *F*=96,485 C mol^−1^ the Faraday constant.$$E_{GSH} = E_{GSH}^{{^\circ}'} - \frac{RT}{2F}\ln\frac{\left\lbrack GSH \right\rbrack^{2}}{\left\lbrack GSSG \right\rbrack}$$

It is widely accepted that *E*~GSH~ in the endoplasmic reticulum (ER) is more oxidizing (*i.e.* higher) than in other non-secretory organelles such as mitochondria, nucleus, or the cytosol [@bib4]. This makes sense, because the ER is the site where disulfide bonds are being synthetized and transferred onto nascent secretory and membrane proteins [@bib5]. Relatively oxidizing ER redox conditions were originally reported based on the measurement of the \[GSH\]:\[GSSG\] ratio in all compartments of the secretory pathway (including the ER) in hybridoma cells as 1:1--3:1 [@bib6]. This was achieved by analyzing the thiol-disulfide state of a small glycopeptide, which directly, but probably not specifically reacted with GSH--GSSG. To derive *E*~GSH~ from these ratios, the authors went on to estimate the cellular concentration of total glutathione \[GS~tot~\](=\[GSH\]+2\[GSSG\]) as 8 mM and assumed \[GS~tot~\] in the secretory pathway to either equal this concentration or to be eight times lower, which returned *E*~GSH~ values of −170 to −185 mV or −133 to −165 mV, respectively [@bib6]. Subsequent studies using isolated ER-membrane vesicles ("microsomes") reported \[GSH\]:\[GSSG\] ratios of 3:1--6:1 [@bib7; @bib8]. However, as GSH can leak through the microsomal membrane [@bib9], these ratios and the derived *E*~GSH~ values based on microsomal \[GS~tot~\] may not reflect the situation in the ER of living cells.

Recently, *E*~GSH~ in the ER of intact HeLa cells was directly measured as −208±4 mV using a glutathione-specific redox-sensitive variant of green fluorescent protein [@bib10]. On the basis of this finding, it was concluded that either \[GS~tot~\] in the ER (\[GS~tot~\]~ER~) exceeds cellular \[GS~tot~\] (\[GS~tot~\]~cell~) or that the \[GSH\]:\[GSSG\] ratio in the ER of live cells is ≥11:1. Here, we found that a single-cysteine glutaredoxin targeted to the ER is at least 92% oxidized *in situ* at steady state. As sCGrx1p rapidly attains equilibrium with \[GSH\]:\[GSSG\] through autocatalyzed glutathionylation [@bib11], this suggests that in the ER, \[GSH\]:\[GSSG\] is less than 7:1 and, consequently, \[GS~tot~\]~ER~ significantly greater than \[GS~tot~\]~cell~.

Materials and methods {#s0010}
=====================

Cloning of sCGrx1p~ER~ {#s0015}
----------------------

The coding sequence of sCGrx1p was amplified by PCR from pOB3 [@bib12] to include a C-terminal KDEL extension and ligated via KpnI/HindIII in frame into a plasmid harboring the ER signal sequence of ERp44 and an HA epitope upstream of a KpnI site (kindly provided by Roberto Sitia, Milan, Italy) [@bib13].

Cell culture and transfection {#s0020}
-----------------------------

HeLa cells were cultivated in Dulbecco\'s Modified Eagle\'s Medium (DMEM) containing 4.5 g/l glucose supplemented with 10% fetal bovine serum, 100 U/ml penicillin, 100 µg streptomycin at 37 °C in 5% CO~2~ and transfected with Turbofect (Fermentas) according to the manufacturer\'s protocols.

Metabolic labeling and immunoprecipitation {#s0025}
------------------------------------------

Transfected HeLa cells were washed with phosphate-buffered saline (PBS) and labeled overnight in complete DMEM cultivation medium containing 50 μCi/ml EasyTag EXPRESS ^35^S protein labeling mix (PerkinElmer Life Sciences). Chase was in DMEM containing 10 mM [l]{.smallcaps}-methionine. For immunoprecipitation, the cells were washed with cold PBS, lysed for 1 h on ice in lysis buffer \[100 mM Na phosphate, 1% Triton X-100, pH 8, 0.2 mM phenyl methyl sulphonyl fluoride (PMSF)\], and the lysate centrifuged at 17,000 g for 1 hour at 4°. The supernatant was added to protein A-Sepharose beads (Life Technologies) carrying prebound anti-HA antibodies (clone 12CA5, kindly provided by Hans-Peter Hauri). After overnight incubation at 4° on a rotary shaker, the beads were washed four times with lysis buffer and once with PBS.

TMM(PEG)~12~ modification protocol {#s0030}
----------------------------------

To block the sulfhydryl groups of free cysteines *in situ*, cell monolayers were washed with ice-cold PBS containing 20 mM N-ethylmaleimide (NEM; Sigma), and incubated in the same buffer on ice for 20 min. After immunoprecipitation, as described above, proteins were released from the beads by incubation in 40 μl 80 mM Tris/HCl, pH7.0, 2% SDS for 5 min in a heat block at 97 °C, followed by vortexing for 5 s. Then, 40 μl of supernatant was transferred to a tube containing 2 μl of 200 mM Tris(2-carboxyethyl)phosphine (TCEP; Sigma; \~10 mM final concentration) and incubated for 10 min at room temperature to reduce the active-site cysteine, which was then alkylated for 1 h at room temperature in 15 mM maleimide-activated polyethylene glycol (TMM(PEG)~12~; Thermo Scientific; 5.5 μl of 125 mM stock added and carefully mixed). Excess TMM(PEG)~12~ was removed by protein precipitation by using methanol/chloroform as previously described [@bib14]. The extent of TMM(PEG)~12~ modification was determined by 16% SDS-PAGE and imaging of the dried gel on a Typhoon phosphorimager (GE Healthcare).

Determination of \[GS~tot~\]~cell~ {#s0035}
----------------------------------

A total of 1.8×10^6^ HeLa cells were seeded into a 10 cm dish and incubated at 37° for 48 h. To measure the cell number and diameter, cells were harvested by trypsinization and the suspension analyzed in a Luna^™^ automated cell counter (Logos Biosystems). Cell viability, as determined by Trypan blue exclusion, was routinely\>90%. Total cell volume was calculated by multiplying the single cell volume (by standard sphere formula) and cell count per ml of cell suspension. 1 ml of cell suspension was gently pelleted, the supernatant discarded and the cell pellet resuspended in 1 ml of 1% sulfosalicylic acid followed by incubation on ice for 15 min. Precipitated proteins were pelleted by centrifugation and the supernatant subjected to a 5,5\'-dithiobis(2-nitro-benzoic acid)--glutathione reductase assay to measure \[GS~tot~\] [@bib15]. This concentration and the total cell volume were used to calculate \[GS~tot~\]~cell~.

Densitometry {#s0040}
------------

Western blots were densitometrically quantified using the ImageJ software (available at <http://rsbweb.nih.gov/ij/>). For the quantification of Phosphorimager scans, the ImageQuant 5.2 software (GE Healthcare) was used.

### Additional methods {#s0045}

Indirect immunofluorescence staining, 4-acetamido-4\'-maleimidylstilbene-2,2\'-disulphonic acid (AMS; Life Technologies) modification, Western blot, and the XBP1 splicing assay were performed as before [@bib10].

Results and discussion {#s0050}
======================

Principle of \[GSH\]:\[GSSG\] determination in the ER {#s0055}
-----------------------------------------------------

With the aim to monitor the \[GSH\]:\[GSSG\] ratio in the ER of live cells, we fused the C30S mutant of yeast glutaredoxin 1 (sCGrx1p) with N-terminal signal peptide and HA-tag and C-terminal KDEL ER retrieval motif ([Fig. 1](#f0005){ref-type="fig"}A). This mutant is known to catalyze its own glutathionylation by reacting with one molecule of GSSG according to Eq. [(2)](#eq0010){ref-type="disp-formula"} [@bib11].$$\left. {sCGrx}1{pSH} + {GSSG}\rightleftarrows{sCGrx}1{pSSG} + {GSH} \right.$$The equilibrium constant *K*~*ox*~ of the above reaction (Eq. [(3)](#eq0015){ref-type="disp-formula"}) has been determined by two independent methods with similar outcomes [@bib11], whereas the value of 74±6 derived from MALDI-TOF mass spectrometry was considered quantitative.$$K_{ox} = \frac{\left\lbrack {{sCGrx}1{pSSG}} \right\rbrack\left\lbrack {GSH} \right\rbrack}{\left\lbrack {{sCGrx}1{pSH}} \right\rbrack\left\lbrack {GSSG} \right\rbrack}$$Autocatalyzed equilibration of the sCGrx1p SH--sCGrx1p SSG and the GSH--GSSG redox couples occurs rapidly *in vitro* [@bib11; @bib16]. Based on this, we assumed this reaction to be at kinetic equilibrium even in a complex mixture of redox couples as present in the lumen of the ER. Thus, using the experimentally determined \[sCGrx1pSH\]:\[sCGrx1pSSG\] ratio and *K*~*ox*~, the \[GSH\]:\[GSSG\] ratio *R*~*GS*~ can be calculated according to Eq. [(4)](#eq0020){ref-type="disp-formula"}.$$R_{GS} = \frac{\left\lbrack {GSH} \right\rbrack}{\left\lbrack {GSSG} \right\rbrack} = K_{ox}\frac{\left\lbrack {{sCGrx}1{pSH}} \right\rbrack}{\left\lbrack {{sCGrx}1{pSSG}} \right\rbrack}$$We expressed ER-targeted sCGrx1p (sCGrx1p~ER~) in HeLa cells and confirmed its correct localization, which overlapped with that of endogenous protein disulfide isomerase (PDI), by indirect immunofluorescence microscopy using anti-HA ([Fig. 1](#f0005){ref-type="fig"}B+C). Specifically, since both our antibody against the ER marker PDI and anti-HA are of mouse origin, we co-expressed the ER-targeted fluorescent protein HyPer~ER~ [@bib17] and found co-localization with PDI ([Fig. 1](#f0005){ref-type="fig"}B) and with sCGrx1p~ER~ ([Fig. 1](#f0005){ref-type="fig"}C).

Expression of sCGrx1p~ER~ does not disturb ER homeostasis {#s0060}
---------------------------------------------------------

Although PDI family members can catalyze protein deglutathionylation reactions to some extent [@bib18], the ER in mammalian cells does not harbor *bona fide* glutaredoxin enzymes [@bib19]. Accordingly, introduction of an exogenous glutaredoxin such as sCGrx1p~ER~ could disturb ER redox homeostasis. It could, for instance, catalyze formation of GSSG from glutathionylated proteins. This could result in a decrease in the \[GSH\]:\[GSSG\] ratio, which in turn would likely elicit unfolded protein response (UPR) stress signaling pathways, as has been observed before [@bib20]. We therefore set out to test these possibilities. To this end, HeLa cells were transfected with sCGrx1p~ER~, empty vector as negative control, or a plasmid encoding the hyperactive ER oxidase Ero1β-C100/130A [@bib10] as positive control for ER hyperoxidation. To probe for the oxidation state of the ER in these cells, we used a previously established electrophoretic mobility shift assay based on the alkylation of cysteine residues in the ER-resident, PDI-related oxidoreductase ERp57 [@bib14; @bib21]. Expression of sCGrx1p~ER~ did not increase the oxidation of ERp57, whereas expression of Ero1β-C100/130A did as expected ([Fig. 2](#f0010){ref-type="fig"}A).

We next examined two established pathways of the mammalian UPR under the same experimental conditions, namely the phosphorylation of double stranded RNA-activated protein kinase (PKR)-like ER kinase (PERK) and the splicing of X-box binding protein 1 (XBP1) mRNA [@bib22]. As shown in [Fig. 2](#f0010){ref-type="fig"}B, neither PERK phosphorylation nor XBP1 splicing was detected in cells expressing sCGrx1p~ER~. In contrast, treatment of cells with DTT, an established trigger of the UPR, readily activated both PERK and XBP1.

These data are in agreement with a previous study where human Grx1 and fusion proteins thereof expressed in the ER of HeLa cells did not cause any detectable redox and stress responses [@bib10]. Likewise, it should be noted that the reported findings are not entirely unexpected, since in an oxidizing environment like the ER [@bib6; @bib10], glutaredoxin-mediated catalysis of protein deglutathionylation has been found to be weak [@bib18]. We concluded that sCGrx1p~ER~ was well-suited as a sensor for \[GSH\]:\[GSSG\] in the ER, as it localized specifically to this compartment without detectably disturbing the local redox conditions.

sCGrx1p~ER~ is not rapidly degraded {#s0065}
-----------------------------------

Since the native environment of Grx1p is the yeast cytosol [@bib23], we next tested the stability of sCGrx1p in the ER. To this end, we performed pulse-chase experiments using HeLa cells where sCGrx1p~ER~ was transiently expressed. Cells were metabolically labeled with ^35^S-methionine to steady state overnight followed by incubation for 0--3 h in media containing an excess of unlabeled methionine (chase). sCGrx1p~ER~ was not significantly degraded during the chase, indicating that it is reasonably stable in the ER ([Fig. 3](#f0015){ref-type="fig"}A+B).

sCGrx1p~ER~ is predominantly glutathionylated at steady state {#s0070}
-------------------------------------------------------------

Via its only cysteine in the mature protein, Cys^27^, sCGrx1p~ER~ reacts with GSSG leading to glutathionylation of Cys^27^ (Eq. [(2)](#eq0010){ref-type="disp-formula"}). To examine the extent of Cys^27^ glutathionylation in living cells, we employed a cysteine-specific alkylation protocol of immunoprecipitated protein, which was previously used to assay the thiol-disulfide state of PDI [@bib14]. Thus, sCGrx1p~ER~ was expressed and metabolically labeled in HeLa cells, and the non-glutathionylated fraction of Cys^27^ (in the thiol form) was allowed to react with NEM added to the cell monolayer. Following immunoprecipitation, glutathionylation was reversed with TCEP, and the resulting reduced cysteine alkylated with TMM(PEG)~12~, which decreased the mobility of sCGrx1p~ER~ in SDS-PAGE. Autoradiography revealed that the vast majority of sCGrx1p~ER~ was TMM(PEG)~12~-modified at steady state ([Fig. 4](#f0020){ref-type="fig"}). Conversely, sCGrx1p~ER~ that was subjected to NEM-alkylation after treatment of cells with DTT ran at the mobility of the unmodified protein (compare [Figs. 3 and 4](#f0015 f0020){ref-type="fig"}), indicating that reduced sCGrx1p~ER~ can quantitatively react with NEM *in situ*.

The percentage of sCGrx1p~ER~ glutathionylation (OxD) was determined by quantifying the intensity of TMM(PEG)~12~-modified and -non-modified bands by densitometry. To exclude incompletely folded sCGrx1p~ER~ from the analysis, we only considered sCGrx1p~ER~ ^35^S-signals that were obtained after a 1 h chase period ([Fig. 4](#f0020){ref-type="fig"}). Analysis of three independent experiments returned an OxD value of 92±3% corresponding to a \[sCGrx1pSH\]:\[sCGrx1pSSG\] ratio of 0.085±0.033 ([Table 1](#t0005){ref-type="table"}). According to Eq. [(4)](#eq0020){ref-type="disp-formula"}, this translates into a \[GSH\]:\[GSSG\] ratio *R*~*GS*~ of 6.3. As densitometric determination of an OxD value\>90% is imprecise and most likely results in an underestimation of OxD, we conservatively concluded that \[GSH\]:\[GSSG\] in the ER of HeLa cells is less than 7:1 ([Table 1](#t0005){ref-type="table"}).

Calculation of \[GS~tot~\]~ER~ {#s0075}
------------------------------

Having obtained a value for \[GSH\]:\[GSSG\] (*R*~*GS*~) in the ER of live cells, we set out to calculate \[GS~tot~\]~ER~. To achieve this, we used the published value of *E*~GSH~(ER) of -208 mV [@bib10], which can also be expressed as \[GSH\]^2^:\[GSSG\]=83 mM (see Eq. [(1)](#eq0005){ref-type="disp-formula"} and [Table 1](#t0005){ref-type="table"}). \[GSH\]^2^:\[GSSG\] and *R*~*GS*~ are converted into \[GS~tot~\]~ER~=\[GSH\]+2\[GSSG\] according to Eq. [(5)](#eq0025){ref-type="disp-formula"}.$$\left\lbrack {GS}_{tot} \right\rbrack_{ER}(M) = \frac{0.083}{R_{GS}} + 2 \times \frac{0.083}{{R_{GS}}^{2}}$$Using *R*~*GS*~=7, Eq. [(5)](#eq0025){ref-type="disp-formula"} returns a value for \[GS~tot~\]~ER~ of 15.2 mM. However, since *R*~*GS*~ is likely less than 7 (see above), the total glutathione concentration in the ER may in reality significantly exceed 15 mM ([Table 1](#t0005){ref-type="table"}).

The ER membrane maintains a \[GS~tot~\] gradient {#s0080}
------------------------------------------------

Intracellular glutathione concentrations range between 0.5 and 15 mM [@bib1]. We were therefore interested in relating \[GS~tot~\]~ER~ with \[GS~tot~\]~cell~ in our particular experimental system. To this end, we determined the average cell volume of trypsinized HeLa cells as described in Materials and methods and measured the total glutathione content of cells, which were gently pelleted from the same suspension, using the established glutathione reductase recycling assay. The obtained values of 2.2 pl average cell volume and \~7 mM \[GS~tot~\]~cell~ ([Table 2](#t0010){ref-type="table"}) are in good agreement with previous measurements [@bib24].

Since \[GS~tot~\]~cell~ is the sum of \[GS~tot~\]~ER~ and \[GS~tot~\] from all other subcellular compartments including the cytosol, our data suggest that \[GS~tot~\] in the cytosol is significantly lower than \[GS~tot~\]~ER~. Thus, despite the fact that glutathione synthesis takes place in the cytosol, the ER membrane appears to maintain an ascending \[GS~tot~\] gradient ([Fig. 5](#f0025){ref-type="fig"}). We propose that this gradient is the result of the relatively oxidizing milieu in the ER [@bib6; @bib10] and the virtual impermeability of the ER membrane to GSSG [@bib9]. Cytosol-derived GSH can diffuse into the ER where a fraction of it is oxidized to membrane-impermeable GSSG [@bib25]. This process is expected to lower \[GSH\]~ER~ and to set up a driving force for further import of GSH from the cytosol. According to this model, the ER would constitute a trap for cellular glutathione, which is reminiscent of the mechanism of osmosis where an impermeable metabolite drives the diffusion of a permeable metabolite across a selectivity barrier such as a biological membrane.

Conclusions {#s0085}
===========

Measuring compartment-specific \[GS~tot~\] is a challenging task [@bib1]. In this study, we addressed the question whether or not glutathione is uniformly distributed among two subcellular compartments, cytosol and ER. For this purpose, we implemented a novel strategy to calculate \[GS~tot~\] in the ER by using a combination of two readouts, which report \[GSH\]^2^:\[GSSG\] (Grx1-roGFP1-iE; [@bib10]) and \[GSH\]:\[GSSG\] (sCGrx1p; this study), respectively. Our work comes to the surprising conclusion that \[GS~tot~\]~ER~ is considerably higher than \[GS~tot~\]~cell~ and, thus, \[GS~tot~\] in the cytosol. As the literature so far assumed that \[GS~tot~\]~ER~ would either equal \[GS~tot~\]~cell~ or be lower [@bib6], this finding is remarkable and may change the way we think about intracellular glutathione fluxes and its role in specific cellular organelles.

Since \[GS~tot~\]~cell~ varies in different cell types and different physiological settings [@bib1], it is likely that the \[GS~tot~\] gradient across the ER membrane shows variability in different *in vivo* models compared to HeLa cells. Nonetheless, we propose that a relatively high \[GS~tot~\]~ER~ constitutes a general characteristic of ER physiology. Since the trapping of cytosolic GSH into the ER, which is known to bring about reductive input [@bib21; @bib26; @bib27], is directly driven by the organelle\'s oxidation level (see [Fig. 5](#f0025){ref-type="fig"}), we further suggest that \[GS~tot~\]~ER~ is an adjustable and "homeostatic" parameter. The ER and the extracellular space have similar redox conditions and calcium concentration [@bib28]. In contrast, our measurement of a high \[GS~tot~\]~ER~ discloses a noteworthy distinguishing feature, as extracellular \[GS~tot~\] is low [@bib2].
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![Targeting of sCGrx1p to the ER. (A) Schematic representation of sCGrx1p~ER~. The active site Cys^27^ is either reduced (--SH) or glutathionylated (--SSG). SP, ER signal peptide; HA, hemagglutinin epitope; KDEL, ER retrieval motif. (B) HyPer~ER~ (green) was transfected into HeLa cells and the cells stained with αPDI followed by a red-fluorescent goat-anti-mouse antibody. (C) HeLa cells were co-transfected with HyPer~ER~ (green) and sCGrx1p~ER~, which was stained with αHA/goat-anti-mouse (red). Merged images are shown in the bottom panel, and white arrows highlight examples of co-localizing structures. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)](gr1){#f0005}

![sCGrx1p~ER~ neither causes ER hyperoxidation nor ER stress. (A) HeLa cells were transfected with the indicated constructs for 24 h or, to obtain fully reduced or oxidized control samples, treated with DTT (10 mM for 5 min) or diamide (5 mM for 5 min), respectively. Free cysteines were alkylated *in situ* with NEM. After cell lysis, proteins were reduced with TCEP and re-alkylated with AMS, and the modified lysates analyzed by SDS-PAGE and anti-ERp57 western blot (WB). The AMS-modified, oxidized fraction of ERp57 (ox) runs slower than the reduced fraction (red). Oxidized fractions, as determined by densitometry, are indicated in percent (% ox). Results of two independent experiments (EXP I and EXP II) are shown. (B) HeLa cells were transfected as in panel (A) or treated with DTT (2 mM for 1 h). The phosphorylation/activation of PERK was analyzed by anti-PERK western blot based on the decreased mobility of the phosphorylated protein (asterisk). In equivalent cell samples, total RNA was isolated and subjected to rtPCR analysis using primers specific for XBP1. Splicing of XBP1 mRNA is evident by the appearance of the spliced (s) and the hybrid (h) forms, as opposed to the unspliced (u) form.](gr2){#f0010}

![Pulse-chase analysis of sCGrx1p~ER~. (A) HeLa cells transfected or not with sCGrx1p~ER~ were labeled with ^35^S-methionine overnight and chased for the indicated time periods. sCGrx1p~ER~ was isolated by anti-HA immunoprecipitation and analyzed by SDS-PAGE and phosphorimaging. (B) Densitometric analysis of sCGrx1p~ER~ band intensity (*n*=3; mean±SEM).](gr3){#f0015}

![Redox state analysis of sCGrx1p~ER~. HeLa cells were transfected or not with sCGrx1p~ER~, pulsed overnight with ^35^S-methionine and chased for the indicated time periods. NEM-modified cell lysates were subjected to anti-HA immunoprecipitation, and the immunoprecipitates treated with TCEP and TMM(PEG)~12~ as described in Materials and methods. Samples were separated by SDS-PAGE and visualized on a phosphorimager. Where indicated, cells were treated with DTT or diamide prior to NEM-alkylation as in [Fig. 2](#f0010){ref-type="fig"}A.](gr4){#f0020}

![Schematic cartoon of a detail of a HeLa cell depicting the trapping of cellular glutathione in the ER. GSH can freely enter the ER (light brown) from the cytosol (cyto, light gray) where some of it is converted to GSSG through the action of the resident machinery for oxidative protein folding. GSSG cannot (or only inefficiently) diffuse back into the cytosol. Thus, as the concentration of GSH can equilibrate between luminal and cytosolic side of the ER membrane, \[GS~tot~\] is significantly higher in the ER than in the cytosol.](gr5){#f0025}

###### 

Glutathione-related redox parameters measured in the endoplasmic reticulum (ER) of HeLa cells.

  Parameter (ER, HeLa)           Value         Reference
  ------------------------------ ------------- ------------
  OxD~sCGrx1p~                   92±3%         This study
  \[sCGrx1pSH\]:\[sCGrx1pSSG\]   0.085±0.033   This study
  \[GSH\]:\[GSSG\] (*R*~*GS*~)   \<7           This study
  \[GSH\]^2^:\[GSSG\]            83 mM         [@bib10]
  \[GS~tot~\]                    \>15 mM       This study

###### 

Determination of \[GS~tot~\]~cell~ in HeLa cells.

  Parameter (HeLa)      Value
  --------------------- ---------------------------
  Average cell volume   2.2 pl (1 pl=10^3^ μm^3^)
  \[GS~tot~\]~cell~     6.9±2.6 mM
